Company BioLineRx Ltd. TEL AVIV STOCK EXCHANGE

Equities

BLRX

IL0011015182

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Bio Therapeutic Drugs

Inactive Instrument

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

ILS in Million	2022	Weight	2023	Weight	Delta
License 96.0 %	-	-	17	96.0 %	-
Oncology and Hematology 4.0 %	0	nan %	1	4.0 %	-

ILS in Million	2022	Weight	2023	Weight	Delta
Israel 100.0 %	0	nan %	18	100.0 %	-

Managers	Title	Age	Since
Philip Serlin CEO	Chief Executive Officer	63	23/05/09
Mali Zeevi DFI	Director of Finance/CFO	48	31/12/08
Irit Gliko-Kabir CTO	Chief Tech/Sci/R&D Officer	-	31/08/17
John Lacey IRC	Investor Relations Contact	-	-
Asaf Aloni PRN	Corporate Officer/Principal	-	-
Tali Yaron Dalah AUD	Comptroller/Controller/Auditor	46	-
Ella Sorani PRN	Corporate Officer/Principal	56	31/01/17
Holly May PRN	Corporate Officer/Principal	-	15/06/22
Tsipi Keren-Lehrer PRN	Corporate Officer/Principal	-	31/07/19

Members of the board	Title	Age	Since
Sandra Panem BRD	Director/Board Member	77	23/02/14
Avraham Molcho BRD	Director/Board Member	66	31/12/09
Aharon Schwartz CHM	Chairman	80	31/12/03
Barbara-Jean Bormann-Kennedy BRD	Director/Board Member	65	18/08/13
Raf Hofstein BRD	Director/Board Member	74	31/12/02
Rami Dar BRD	Director/Board Member	67	30/06/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,086,589,165	1,086,589,164 ( 100.00 %)	0	100.00 %

Name	Equities	%	Valuation
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 8.543 %	102,437,055	8.543 %	5 M ₪
Aharon Schwartz 0.3090 %	3,705,000	0.3090 %	179 989 ₪
KSM Mutual Funds Ltd. 0.2189 %	2,625,240	0.2189 %	127 534 ₪
Migdal Mutual Funds Ltd. 0.1115 %	1,337,063	0.1115 %	64 955 ₪
Mali Zeevi 0.0274 %	328,665	0.0274 %	15 967 ₪
Dimensional Fund Advisors Ltd. 0.0255 %	305,918	0.0255 %	14 861 ₪
Philip Serlin 0.0143 %	171,900	0.0143 %	8 351 ₪
Ayalon Mutual Funds Ltd. 0.0122 %	146,813	0.0122 %	7 132 ₪
Ella Sorani 0.005517 %	66,150	0.005517 %	3 214 ₪
Avraham Molcho 0.000000 %	0	0.000000 %	- ₪

Name	Equities	%	Valuation
Morgan Stanley Capital Services LLC 0.3645 %	291,354	0.3645 %	217 350 ₪
Susquehanna Securities LLC 0.2563 %	204,914	0.2563 %	152 866 ₪
Values First Advisors, Inc. 0.2547 %	203,633	0.2547 %	151 910 ₪
LPL Financial LLC 0.1255 %	100,323	0.1255 %	74 841 ₪
Western International Securities, Inc. 0.1243 %	99,333	0.1243 %	74 102 ₪
PVG Asset Management Corp. 0.0774 %	61,840	0.0774 %	46 133 ₪
RBC Dominion Securities, Inc. 0.0681 %	54,471	0.0681 %	40 635 ₪
Geode Capital Management LLC 0.0500 %	39,993	0.0500 %	29 835 ₪
RATHBONES GROUP PLC 0.0498 %	39,820	0.0498 %	29 706 ₪
Geneos Wealth Management, Inc. 0.0482 %	38,500	0.0482 %	28 721 ₪

BioLineRx Ltd.

Modi'in Technology Park 2 HaMa'ayan Street

7177871, Modi'in

+972 8 642 9100

http://www.biolinerx.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+16.45%	122B
REGENERON PHARMACEUTICALS, INC.	+21.96%	116B
ARGENX SE	+25.44%	27.03B
BIONTECH SE	-20.05%	20.36B
BEIGENE, LTD.	-16.28%	15.91B
GENMAB A/S	-16.29%	16.43B
WUXI APPTEC CO., LTD.	-44.35%	15.6B
SAREPTA THERAPEUTICS, INC.	+63.91%	14.94B
NEUROCRINE BIOSCIENCES, INC.	+2.52%	13.59B

Bio Therapeutic Drugs